Research ArticleOriginal Article
Open Access

Periodontal findings in systemic lupus erythematosus patients and healthy controls

Khalid D. Al-Mutairi, Mohammad S. Al-Zahrani, Sami M. Bahlas, Rayyan A. Kayal and Khalid H. Zawawi
Saudi Medical Journal January 2015, 36 (4) 463-468; DOI: https://doi.org/10.15537/smj.2015.4.10746

References

  1. ↵
    1. Al-Zahrani MS,
    2. Kayal RA
    (2006) Alveolar bone loss and reported medical status among a sample of patients at a Saudi dental school. Oral Health Prev Dent 4:113–118.
    OpenUrlPubMed
  2. ↵
    1. Nair S,
    2. Faizuddin M,
    3. Dharmapalan J
    (2014) Role of autoimmune responses in periodontal disease. Autoimmune Dis 2014:596824.
    OpenUrlPubMed
    1. Al-Zahrani MS,
    2. Zawawi KH,
    3. Altaf FM
    (2013) The effect of obesity and periodontitis on the expression of antimicrobial peptides in gingival tissues. Saudi Med J 34:525–530.
    OpenUrl
  4. ↵
    1. Bartold PM,
    2. Van Dyke TE
    (2013) Periodontitis: a host-mediated disruption of microbial homeostasis. Unlearning learned concepts. Periodontol 2000 62:203–217.
    OpenUrl
  5. ↵
    1. Al-Katma MK,
    2. Bissada NF,
    3. Bordeaux JM,
    4. Sue J,
    5. Askari AD
    (2007) Control of periodontal infection reduces the severity of active rheumatoid arthritis. J Clin Rheumatol 13:134–137.
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    1. Ortiz P,
    2. Bissada NF,
    3. Palomo L,
    4. Han YW,
    5. Al-Zahrani MS,
    6. Panneerselvam A,
    7. et al.
    (2009) Periodontal therapy reduces the severity of active rheumatoid arthritis in patients treated with or without tumor necrosis factor inhibitors. J Periodontol 80:535–540.
    OpenUrlCrossRefPubMedWeb of Science
    1. Scher JU,
    2. Bretz WA,
    3. Abramson SB
    (2014) Periodontal disease and subgingival microbiota as contributors for rheumatoid arthritis pathogenesis: modifiable risk factors? Curr Opin Rheumatol 26:424–429.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Fabbri C,
    2. Fuller R,
    3. Bonfa E,
    4. Guedes LK,
    5. D’Alleva PS,
    6. Borba EF
    (2014) Periodontitis treatment improves systemic lupus erythematosus response to immunosuppressive therapy. Clin Rheumatol 33:505–509.
    OpenUrlPubMed
  9. ↵
    1. Manson JJ,
    2. Rahman A
    (2006) Systemic lupus erythematosus. Orphanet J Rare Dis 1:6.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Al-Arfaj AS,
    2. Al-Balla SR,
    3. Al-Dalaan AN,
    4. Al-Saleh SS,
    5. Bahabri SA,
    6. Mousa MM,
    7. et al.
    (2002) Prevalence of systemic lupus erythematosus in central Saudi Arabia. Saudi Med J 23:87–89.
    OpenUrlPubMedWeb of Science
  11. ↵
    1. Al-Arfaj AS,
    2. Khalil N
    (2009) Clinical and immunological manifestations in 624 SLE patients in Saudi Arabia. Lupus 18:465–473.
    OpenUrlCrossRefPubMedWeb of Science
  12. ↵
    1. Fernando MM,
    2. Isenberg DA
    (2005) How to monitor SLE in routine clinical practice. Ann Rheum Dis 64:524–527.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. Adhya Z,
    2. Borozdenkova S,
    3. Karim MY
    (2011) The role of cytokines as biomarkers in systemic lupus erythematosus and lupus nephritis. Nephrol Dial Transplant 26:3273–3280.
    OpenUrlCrossRefPubMed
  14. ↵
    1. Mikdashi J,
    2. Handwerger B
    (2004) Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort. Rheumatology (Oxford) 43:1555–1560.
    OpenUrlCrossRefPubMedWeb of Science
    1. Toloza SM,
    2. Roseman JM,
    3. Alarcon GS,
    4. McGwin G Jr.,
    5. Uribe AG,
    6. Fessler BJ,
    7. et al.
    (2004) Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXII. Predictors of time to the occurrence of initial damage. Arthritis Rheum 50:3177–3186.
    OpenUrlCrossRefPubMedWeb of Science
    1. Vila LM,
    2. Alarcon GS,
    3. McGwin G Jr.,
    4. Bastian HM,
    5. Fessler BJ,
    6. Reveille JD,
    7. et al.
    (2005) Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXIX. Elevation of erythrocyte sedimentation rate is associated with disease activity and damage accrual. J Rheumatol 32:2150–2155.
    OpenUrlAbstract/FREE Full Text
    1. Yee CS,
    2. Hussein H,
    3. Skan J,
    4. Bowman S,
    5. Situnayake D,
    6. Gordon C
    (2003) Association of damage with autoantibody profile, age, race, sex and disease duration in systemic lupus erythematosus. Rheumatology (Oxford) 42:276–279.
    OpenUrlCrossRefPubMedWeb of Science
  18. ↵
    1. Munoz LE,
    2. Gaipl US,
    3. Herrmann M
    (2008) Predictive value of anti-dsDNA autoantibodies: importance of the assay. Autoimmun Rev 7:594–597.
    OpenUrlCrossRefPubMedWeb of Science
  19. ↵
    1. Pisetsky DS
    (2012) Antinuclear antibodies in rheumatic disease: a proposal for a function-based classification. Scand J Immunol 76:223–228.
    OpenUrlCrossRefPubMed
  20. ↵
    1. Schenkein HA,
    2. Best AM,
    3. Brooks CN,
    4. Burmeister JA,
    5. Arrowood JA,
    6. Kontos MC,
    7. et al.
    (2007) Anti-cardiolipin and increased serum adhesion molecule levels in patients with aggressive periodontitis. J Periodontol 78:459–466.
    OpenUrlCrossRefPubMed
  21. ↵
    1. Kobayashi T,
    2. Ito S,
    3. Yasuda K,
    4. Kuroda T,
    5. Yamamoto K,
    6. Sugita N,
    7. et al.
    (2007) The combined genotypes of stimulatory and inhibitory Fc gamma receptors associated with systemic lupus erythematosus and periodontitis in Japanese adults. J Periodontol 78:467–474.
    OpenUrlCrossRefPubMed
  22. ↵
    1. Nagler RM,
    2. Lorber M,
    3. Ben-Arieh Y,
    4. Laufer D,
    5. Pollack S
    (1999) Generalized periodontal involvement in a young patient with systemic lupus erythematosus. Lupus 8:770–772.
    OpenUrlCrossRefPubMedWeb of Science
  23. ↵
    1. Tietmann C,
    2. Bissada NF
    (2006) Aggressive periodontitis in a patient with chronic cutaneous lupus erythematosus: a case report. Quintessence Int 37:401–408.
    OpenUrlPubMed
  24. ↵
    1. Mutlu S,
    2. Richards A,
    3. Maddison P,
    4. Scully C
    (1993) Gingival and periodontal health in systemic lupus erythematosus. Community Dent Oral Epidemiol 21:158–161.
    OpenUrlCrossRefPubMedWeb of Science
  25. ↵
    1. Hochberg MC
    (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725.
    OpenUrlCrossRefPubMedWeb of Science
  26. ↵
    1. Bascones-Martinez A,
    2. Gonzalez-Febles J,
    3. Sanz-Esporrin J
    (2014) Diabetes and periodontal disease. Review of the literature. Am J Dent 27:63–67.
    OpenUrlPubMed
    1. Sharma A,
    2. Astekar M,
    3. Metgud R,
    4. Soni A,
    5. Verma M,
    6. Patel S
    (2014) A study of C-reactive protein, lipid metabolism and peripheral blood to identify a link between periodontitis and cardiovascular disease. Biotech Histochem 89:577–582.
    OpenUrl
    1. Kalburgi V,
    2. Sravya L,
    3. Warad S,
    4. Vijayalaxmi K,
    5. Sejal P,
    6. Hazeil D
    (2014) Role of systemic markers in periodontal diseases: a possible inflammatory burden and risk factor for cardiovascular diseases? Ann Med Health Sci Res 4:388–392.
    OpenUrl
  29. ↵
    1. Al-Zahrani MS,
    2. Kayal RA,
    3. Bissada NF
    (2006) Periodontitis and cardiovascular disease: a review of shared risk factors and new findings supporting a causality hypothesis. Quintessence Int 37:11–18.
    OpenUrlPubMedWeb of Science
  30. ↵
    1. Chai L,
    2. Song YQ,
    3. Leung WK
    (2012) Genetic polymorphism studies in periodontitis and Fcgamma receptors. J Periodontal Res 47:273–285.
    OpenUrlPubMed
  31. ↵
    1. Figueredo CM,
    2. Areas A,
    3. Sztajnbok FR,
    4. Miceli V,
    5. Miranda LA,
    6. Fischer RG,
    7. et al.
    (2008) Higher elastase activity associated with lower IL-18 in GCF from juvenile systemic lupus patients. Oral Health Prev Dent 6:75–81.
    OpenUrlPubMed
  32. ↵
    1. Bertsias G,
    2. Ioannidis JP,
    3. Boletis J,
    4. Bombardieri S,
    5. Cervera R,
    6. Dostal C,
    7. et al.
    (2008) EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis 67:195–205.
    OpenUrlAbstract/FREE Full Text
  33. ↵
    1. Kobayashi T,
    2. Ito S,
    3. Yamamoto K,
    4. Hasegawa H,
    5. Sugita N,
    6. Kuroda T,
    7. et al.
    (2003) Risk of periodontitis in systemic lupus erythematosus is associated with Fcgamma receptor polymorphisms. J Periodontol 74:378–384.
    OpenUrlCrossRefPubMed
  34. ↵
    1. Savioli C,
    2. Ribeiro AC,
    3. Fabri GM,
    4. Calich AL,
    5. Carvalho J,
    6. Silva CA,
    7. et al.
    (2012) Persistent periodontal disease hampers anti-tumor necrosis factor treatment response in rheumatoid arthritis. J Clin Rheumatol 18:180–184.
    OpenUrlPubMed
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section